Latest News

OpenAI has just debuted a major update to its ChatGPT platform with the unveiling of a new general-purpose AI agent. ...

Eli Lilly has taken a commanding position in the obesity drug market with its GLP-1 agonist Zepbound, and now the pharma giant is preparing for ...

Tesla is confronting a barrage of challenges that have rattled its dominance in the EV market and clouded the outlook for its ambitious robotaxi rollout. ...

US stock markets once again had a mixed performance on Friday, with the Dow Jones Industrial Average dipping. ...